{"id":4776,"date":"2016-02-25T09:00:00","date_gmt":"2016-02-25T09:00:00","guid":{"rendered":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/7114-2\/"},"modified":"2024-09-23T11:22:38","modified_gmt":"2024-09-23T11:22:38","slug":"7114-2","status":"publish","type":"post","link":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/7114-2\/","title":{"rendered":"Breakthrough T1D en Sanofi slaan handen ineen voor slimme insuline!"},"content":{"rendered":"<img loading=\"lazy\" decoding=\"async\" class=\"alignright size-medium wp-image-7115\" src=\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/shutterstock_298879511-200x300-1.jpg\" alt=\"shutterstock_298879511\" width=\"200\" height=\"300\" \/>Breakthrough T1D en Sanofi gaan samenwerken om 4 nieuwe onderzoeken naar slimme insuline te financieren. Het doel van het partnerschap is om te zorgen dat de beste variant van slimme insuline in een zo kort mogelijk tijdsbestek beschikbaar komt voor mensen met Type 1 Diabetes.\n<div class=\"text_exposed_show\">\n\nBreakthrough T1D en Sanofi gaan 4 verschillende onderzoeken financieren: drie in Amerika en \u00e9\u00e9n in Australi\u00eb.\n\nIn California ontwikkelt dr. Alborz Mahdavi met zijn bedrijf Protomer Technologies een volledig glucoseresponsieve insuline. Deze insuline reageert op het bloedglucosegehalte in het lichaam en geeft op basis daarvan insuline af. Dr. Mahdavi is een van de drie winnaars van een grote innovatie wedstrijd die Breakthrough T1D in 2013 organiseerde om nieuwe idee\u00ebn voor slimme insuline een kans te geven. Dr. Zhen Gu werkt aan een slimme insuline die via een pleister wordt toegediend. In Utah werkt dr. Danny Chou aan een slimme insuline die deactiveert zodra het bloedglucoselevel onder een bepaald niveau daalt. In Australi\u00eb werkt dr. Christoph Hagemeyer aan een manier om nanodeeltjes te laten reageren op het bloedglucoselevel.\n\nSamen zullen Breakthrough T1D en Sanofi ruim 4,5 miljoen dollar besteden aan deze onderzoeken.\n\n<\/div>","protected":false,"raw":""},"excerpt":{"rendered":"<p>Breakthrough T1D en Sanofi gaan samenwerken om 4 nieuwe onderzoeken naar slimme insuline te financieren. Het doel van het partnerschap is om te zorgen dat de beste variant van slimme insuline in een zo kort mogelijk tijdsbestek beschikbaar komt voor mensen met Type 1 Diabetes. Breakthrough T1D en Sanofi gaan 4 verschillende onderzoeken financieren: drie [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[184,187],"tags":[],"class_list":["post-4776","post","type-post","status-publish","format-standard","hentry","category-archief","category-behandelen"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Breakthrough T1D en Sanofi slaan handen ineen voor slimme insuline! - Breakthrough T1D<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/7114-2\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Breakthrough T1D en Sanofi slaan handen ineen voor slimme insuline! - Breakthrough T1D\" \/>\n<meta property=\"og:description\" content=\"Breakthrough T1D en Sanofi gaan samenwerken om 4 nieuwe onderzoeken naar slimme insuline te financieren. Het doel van het partnerschap is om te zorgen dat de beste variant van slimme insuline in een zo kort mogelijk tijdsbestek beschikbaar komt voor mensen met Type 1 Diabetes. Breakthrough T1D en Sanofi gaan 4 verschillende onderzoeken financieren: drie [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/7114-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Breakthrough T1D\" \/>\n<meta property=\"article:published_time\" content=\"2016-02-25T09:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-23T11:22:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/shutterstock_298879511-200x300-1.jpg\" \/>\n<meta name=\"author\" content=\"ylt-admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Geschreven door\" \/>\n\t<meta name=\"twitter:data1\" content=\"ylt-admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/7114-2\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/7114-2\/\"},\"author\":{\"name\":\"ylt-admin\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6\"},\"headline\":\"Breakthrough T1D en Sanofi slaan handen ineen voor slimme insuline!\",\"datePublished\":\"2016-02-25T09:00:00+00:00\",\"dateModified\":\"2024-09-23T11:22:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/7114-2\/\"},\"wordCount\":197,\"publisher\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/7114-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/shutterstock_298879511-200x300-1.jpg\",\"articleSection\":[\"Archief\",\"Behandelen\"],\"inLanguage\":\"nl-NL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/7114-2\/\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/7114-2\/\",\"name\":\"Breakthrough T1D en Sanofi slaan handen ineen voor slimme insuline! - Breakthrough T1D\",\"isPartOf\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/7114-2\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/7114-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/shutterstock_298879511-200x300-1.jpg\",\"datePublished\":\"2016-02-25T09:00:00+00:00\",\"dateModified\":\"2024-09-23T11:22:38+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/7114-2\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/7114-2\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/7114-2\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/7114-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/breakthrought1d.eu\/nl\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Breakthrough T1D en Sanofi slaan handen ineen voor slimme insuline!\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#website\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/\",\"name\":\"Breakthrough T1D\",\"description\":\"Wij zetten ons in voor een toekomst zonder T1D\",\"publisher\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/breakthrought1d.eu\/nl\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\",\"name\":\"Breakthrough T1D\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png\",\"contentUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png\",\"width\":330,\"height\":141,\"caption\":\"Breakthrough T1D\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6\",\"name\":\"ylt-admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"caption\":\"ylt-admin\"},\"sameAs\":[\"https:\/\/87.250.144.92\"],\"url\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Breakthrough T1D en Sanofi slaan handen ineen voor slimme insuline! - Breakthrough T1D","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/7114-2\/","og_locale":"nl_NL","og_type":"article","og_title":"Breakthrough T1D en Sanofi slaan handen ineen voor slimme insuline! - Breakthrough T1D","og_description":"Breakthrough T1D en Sanofi gaan samenwerken om 4 nieuwe onderzoeken naar slimme insuline te financieren. Het doel van het partnerschap is om te zorgen dat de beste variant van slimme insuline in een zo kort mogelijk tijdsbestek beschikbaar komt voor mensen met Type 1 Diabetes. Breakthrough T1D en Sanofi gaan 4 verschillende onderzoeken financieren: drie [&hellip;]","og_url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/7114-2\/","og_site_name":"Breakthrough T1D","article_published_time":"2016-02-25T09:00:00+00:00","article_modified_time":"2024-09-23T11:22:38+00:00","og_image":[{"url":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/shutterstock_298879511-200x300-1.jpg","type":"","width":"","height":""}],"author":"ylt-admin","twitter_card":"summary_large_image","twitter_misc":{"Geschreven door":"ylt-admin","Geschatte leestijd":"1 minuut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/7114-2\/#article","isPartOf":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/7114-2\/"},"author":{"name":"ylt-admin","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6"},"headline":"Breakthrough T1D en Sanofi slaan handen ineen voor slimme insuline!","datePublished":"2016-02-25T09:00:00+00:00","dateModified":"2024-09-23T11:22:38+00:00","mainEntityOfPage":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/7114-2\/"},"wordCount":197,"publisher":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#organization"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/7114-2\/#primaryimage"},"thumbnailUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/shutterstock_298879511-200x300-1.jpg","articleSection":["Archief","Behandelen"],"inLanguage":"nl-NL"},{"@type":"WebPage","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/7114-2\/","url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/7114-2\/","name":"Breakthrough T1D en Sanofi slaan handen ineen voor slimme insuline! - Breakthrough T1D","isPartOf":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/7114-2\/#primaryimage"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/7114-2\/#primaryimage"},"thumbnailUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/shutterstock_298879511-200x300-1.jpg","datePublished":"2016-02-25T09:00:00+00:00","dateModified":"2024-09-23T11:22:38+00:00","breadcrumb":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/7114-2\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/breakthrought1d.eu\/nl\/nieuws\/7114-2\/"]}]},{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/7114-2\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/7114-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/breakthrought1d.eu\/nl\/"},{"@type":"ListItem","position":2,"name":"Breakthrough T1D en Sanofi slaan handen ineen voor slimme insuline!"}]},{"@type":"WebSite","@id":"https:\/\/breakthrought1d.eu\/nl\/#website","url":"https:\/\/breakthrought1d.eu\/nl\/","name":"Breakthrough T1D","description":"Wij zetten ons in voor een toekomst zonder T1D","publisher":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/breakthrought1d.eu\/nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/breakthrought1d.eu\/nl\/#organization","name":"Breakthrough T1D","url":"https:\/\/breakthrought1d.eu\/nl\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/","url":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png","contentUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png","width":330,"height":141,"caption":"Breakthrough T1D"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6","name":"ylt-admin","image":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","caption":"ylt-admin"},"sameAs":["https:\/\/87.250.144.92"],"url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/"}]}},"_links":{"self":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/4776","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/comments?post=4776"}],"version-history":[{"count":1,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/4776\/revisions"}],"predecessor-version":[{"id":7078,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/4776\/revisions\/7078"}],"wp:attachment":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/media?parent=4776"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/categories?post=4776"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/tags?post=4776"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}